SLC2A1 and early-onset autosomal dominant Alzheimer disease: Based on its essential role in transporting glucose and its participation in pathological processes of various brain diseases such as Alzheimer’s disease, ischemia, and brain tumors, upregulation of GLUT1 has been proposed to treat hypoglycemic conditions, while its downregulation or inhibition could be used to cope with hyperglycemic conditions [133].